Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07584239 · ClinicalTrials.gov registry record · NA

Prehabilitation Physical Therapy and Relaxation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery, ROAR-LCS Trial

A NA study, sponsored by Ohio State University Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
30
Enrollment target

NCT07584239 is a NA study that is actively recruiting participants, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07584239, a NA study, is actively recruiting participants, sponsored by Ohio State University Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This clinical trial tests two different physical therapy and relaxation interventions, one in-person and at-home called Resiliency and Operative Success for Adults Receiving Lung Cancer Surgery (ROAR-LCS) and one virtually called BeFitMe. These programs that take place before and after standard of care lung cancer surgery, called prehabilitation programs, promote resiliency and patient outcomes (operative success) for adults receiving lung cancer surgery. Lung cancers occur in the chest and often cause symptoms for patients. Poor physical performance and negative mood are two risk factors for a decline in functional status after surgery. Physical therapy and relaxation interventions (i.e. progressive muscle relaxation) are two such interventions that may improve physical and emotional recovery including a potential shortened hospital stay for patients receiving surgery for lung cancer. Starting these intervention programs early alongside cancer treatment can improve symptoms, improve functional status and quality of life, help with emotional needs of patients, improve recovery time, and may even prolong life. ROAR-LCS and BeFitMe may promote resiliency and operative success for adults receiving lung cancer surgery.

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Exercise Intervention
  • OTHER Internet-Based Intervention

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-07-15
Est. Completion 2026-12-31
Phase NA

What the Registry Record Tells You About NCT07584239

The ClinicalTrials.gov registry entry for NCT07584239 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Biospecimen Collection is the first listed.

NCT07584239 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07584239 about?

NCT07584239 is a clinical study titled "Prehabilitation Physical Therapy and Relaxation Intervention Program to Promote Resiliency and Operative Success Among Adults Receiving Lung Cancer Surgery, ROAR-LCS Trial". This clinical trial tests two different physical therapy and relaxation interventions, one in-person and at-home called Resiliency and Operative Success for Adults Receiving Lung Cancer Surgery (ROAR-LCS) and one virtually called BeFitMe. These programs that take place before and after standard of c...

What is the current status of trial NCT07584239?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-07-15. Estimated completion is 2026-12-31.

What interventions are being tested in trial NCT07584239?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Exercise Intervention (OTHER), Internet-Based Intervention (OTHER).

Who is sponsoring clinical trial NCT07584239?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.